13.02.2026
A fast start to 2026 signals continued investor confidence in Swiss life sciences
Investor confidence in European life sciences companies is growing and is expected to gain momentum … a CHF 50,000 Propelling Grant from its university before raising CHF 150,000 in seed funding from Venture Kick.
“Venture Kick has played a crucial role in helping GlioCART build a strong corporate and IP …
> zum Detail